{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:49:26Z","timestamp":1793054966592,"version":"4.5.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ejmech.2023.115998","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T22:48:07Z","timestamp":1701211687000},"page":"115998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Recent progress and applications of small molecule inhibitors of Keap1\u2013Nrf2 axis for neurodegenerative diseases"],"prefix":"10.1016","volume":"264","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rangxiao","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115998_bib1","doi-asserted-by":"crossref","first-page":"872471","DOI":"10.3389\/fnmol.2022.872471","article-title":"Research progress of pyroptosis in Alzheimer\u2019s disease","volume":"15","author":"Xue","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2023.115998_bib2","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.3390\/ijms23115938","article-title":"An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases","volume":"23","author":"Teleanu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.115998_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.lfs.2018.12.029","article-title":"Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: etiologies and therapeutic strategies","volume":"218","author":"Elfawy","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2023.115998_bib4","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3390\/antiox9111056","article-title":"Dietary antioxidants and the mitochondrial quality control: their potential roles in Parkinson\u2019s disease treatment","volume":"9","author":"Lee","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2023.115998_bib5","first-page":"721","article-title":"Nrf2-Keap1 signaling in oxidative and reductive stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Bba-Mol. Cell Res."},{"key":"10.1016\/j.ejmech.2023.115998_bib6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.14336\/AD.2018.0513","article-title":"The anti-inflammatory and anti-oxidant mechanisms of the Keap1\/Nrf2\/ARE signaling pathway in chronic diseases,","volume":"10","author":"Tu","year":"2019","journal-title":"Aging Dis"},{"key":"10.1016\/j.ejmech.2023.115998_bib7","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1016\/j.bmc.2010.03.034","article-title":"A novel kavalactone derivative protects against H2O2-induced PC12 cell death via Nrf2\/ARE activation,","volume":"18","author":"Tanaka","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115998_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1479-7364-7-13","article-title":"Update on the Kelch-like (KLHL) gene family","volume":"7","author":"Dhanoa","year":"2013","journal-title":"Hum. Genom."},{"key":"10.1016\/j.ejmech.2023.115998_bib9","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1365-2443.2007.01118.x","article-title":"Subcellular localization and cytoplasmic complex status of endogenous Keap1","volume":"12","author":"Watai","year":"2007","journal-title":"Gene Cell."},{"key":"10.1016\/j.ejmech.2023.115998_bib10","doi-asserted-by":"crossref","first-page":"23719","DOI":"10.1074\/jbc.M116.729418","article-title":"Identification and characterization of MCM3 as a Kelch-like ECH-associated Protein 1 (KEAP1) substrate","volume":"291","author":"Mulvaney","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115998_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Gene Dev."},{"key":"10.1016\/j.ejmech.2023.115998_bib12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.abb.2016.08.005","article-title":"Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants","volume":"617","author":"Dinkova-Kostova","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2023.115998_bib13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/10715769900300881","article-title":"Regulatory mechanisms of cellular response to oxidative stress","volume":"31","author":"Itoh","year":"1999","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ejmech.2023.115998_bib14","first-page":"29","article-title":"Overview of redox regulation by Keap1\u2013Nrf2 system in toxicology and cancer","volume":"1","author":"Suzuki","year":"2016","journal-title":"Curr. Opin"},{"key":"10.1016\/j.ejmech.2023.115998_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12551-016-0244-4","article-title":"The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases,","volume":"9","author":"Deshmukh","year":"2017","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.ejmech.2023.115998_bib16","doi-asserted-by":"crossref","first-page":"105325","DOI":"10.1016\/j.neuint.2022.105325","article-title":"The principal molecular mechanisms behind the activation of Keap1\/Nrf2\/ARE pathway leading to neuroprotective action in Parkinson\u2019s disease","volume":"156","author":"Chakkittukandiyil","year":"2022","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2023.115998_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202200179","article-title":"BTB domains: a structural view of evolution, multimerization, and protein-protein interactions,","volume":"45","author":"Bonchuk","year":"2023","journal-title":"Bioessays"},{"key":"10.1016\/j.ejmech.2023.115998_bib18","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.chembiol.2019.07.011","article-title":"Non-covalent NRF2 activation confers greater cellular protection than covalent activation","volume":"26","author":"Liu","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.115998_bib19","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1128\/MCB.01704-07","article-title":"Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity","volume":"28","author":"Yamamoto","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.115998_bib20","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/med.21396","article-title":"The Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update","volume":"36","author":"Lu","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2023.115998_bib21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.tips.2021.06.005","article-title":"Nrf2 for cardiac protection: pharmacological options against oxidative stress","volume":"42","author":"Chen","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2023.115998_bib22","doi-asserted-by":"crossref","first-page":"23064","DOI":"10.1074\/jbc.M110.121913","article-title":"The ubiquitin-conjugating enzyme UbcM2 can regulate the stability and activity of the antioxidant transcription factor Nrf2","volume":"285","author":"Plafker","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115998_bib23","doi-asserted-by":"crossref","first-page":"27251","DOI":"10.1074\/jbc.M602746200","article-title":"Nrf2 possesses a redox-sensitive nuclear exporting signal in the Neh5 transactivation domain","volume":"281","author":"Li","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115998_bib24","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/MCB.26.8.2887-2900.2006","article-title":"Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model","volume":"26","author":"Tong","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.115998_bib25","doi-asserted-by":"crossref","first-page":"24756","DOI":"10.1074\/jbc.M601119200","article-title":"Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a \"tethering\" mechanism: a two-site interaction model for the Nrf2-Keap1 complex","volume":"281","author":"McMahon","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115998_bib26","doi-asserted-by":"crossref","first-page":"10895","DOI":"10.1128\/MCB.25.24.10895-10906.2005","article-title":"The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation","volume":"25","author":"Nioi","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.115998_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1134\/S0006297922010060","article-title":"Lability of the Nrf2\/Keap\/ARE cell defense system in different models of cell aging and age-related pathologies","volume":"87","author":"Shilovsky","year":"2022","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.ejmech.2023.115998_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/hdi.13084","article-title":"Evaluation of Bach1 mRNA expression in patients with chronic kidney disease: a preliminary study","volume":"27","author":"Mafra","year":"2023","journal-title":"Hemodial. Int."},{"key":"10.1016\/j.ejmech.2023.115998_bib29","doi-asserted-by":"crossref","first-page":"130129","DOI":"10.1016\/j.bbagen.2022.130129","article-title":"Inhibiting BTB domain and CNC homolog 1 (Bach1) as an alternative to increase Nrf2 activation in chronic diseases","volume":"1866","author":"Mafra","year":"2022","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ejmech.2023.115998_bib30","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1158\/0008-5472.CAN-12-3386","article-title":"RXRalpha inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2","volume":"73","author":"Wang","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2023.115998_bib31","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1128\/MCB.00389-16","article-title":"Absolute amounts and status of the Nrf2-Keap1-Cul3 complex within cells","volume":"36","author":"Iso","year":"2016","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.115998_bib32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.phrs.2018.06.013","article-title":"Canonical and non-canonical mechanisms of Nrf2 activation","volume":"134","author":"Silva-Islas","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2023.115998_bib33","doi-asserted-by":"crossref","first-page":"103413","DOI":"10.1016\/j.mcn.2019.103413","article-title":"Crosstalk between Nrf2 signaling and mitochondrial function in Parkinson\u2019s disease","volume":"101","author":"Kaidery","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ejmech.2023.115998_bib34","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/01616412.2016.1249997","article-title":"Role of neuroinflammation and latent transcription factors in pathogenesis of Parkinson\u2019s disease","volume":"38","author":"Pal","year":"2016","journal-title":"Neurol. Res."},{"key":"10.1016\/j.ejmech.2023.115998_bib35","doi-asserted-by":"crossref","first-page":"E4676","DOI":"10.1073\/pnas.1614943114","article-title":"KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington\u2019s disease patients","volume":"114","author":"Quinti","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2023.115998_bib36","doi-asserted-by":"crossref","first-page":"4134928","DOI":"10.1155\/2023\/4134928","article-title":"The protective role of Nrf2 in renal tubular cells in oxidised low-density lipoprotein-induced fibrosis","volume":"8","author":"Long","year":"2023","journal-title":"Anal. Cell Pathol."},{"key":"10.1016\/j.ejmech.2023.115998_bib37","doi-asserted-by":"crossref","first-page":"109763","DOI":"10.1016\/j.intimp.2023.109763","article-title":"ROS-activated MAPK\/ERK pathway regulates crosstalk between Nrf2 and Hif-1alpha to promote IL-17D expression protecting the intestinal epithelial barrier under hyperoxia","volume":"116","author":"Wang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2023.115998_bib38","doi-asserted-by":"crossref","first-page":"L138","DOI":"10.1152\/ajplung.00075.2017","article-title":"Immunomodulators targeting MARCO expression improve resistance to postinfluenza bacterial pneumonia","volume":"313","author":"Wu","year":"2017","journal-title":"Am. J. Physiol.-Lung C"},{"key":"10.1016\/j.ejmech.2023.115998_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10863-022-09953-4","article-title":"G protein-coupled receptor 39 alleviates mitochondrial dysfunction and hepatocyte lipid accumulation via SIRT1\/Nrf2 signaling","volume":"55","author":"Chen","year":"2023","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.ejmech.2023.115998_bib40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1515\/hsz-2015-0295","article-title":"Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function","volume":"397","author":"Esteras","year":"2016","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115998_bib41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.toxlet.2021.10.016","article-title":"Vitamin D3 protects against nitrogen mustard-induced apoptosis of the bronchial epithelial cells via activating the VDR\/Nrf2\/Sirt3 pathway","volume":"354","author":"Yu","year":"2022","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejmech.2023.115998_bib42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.vph.2018.08.009","article-title":"Nrf2 in aging - focus on the cardiovascular system","volume":"112","author":"Kloska","year":"2019","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115998_bib43","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.3390\/jpm12111817","article-title":"Immunosenescence and aging: neuroinflammation is a prominent feature of Alzheimer\u2019s disease and is a likely contributor to neurodegenerative disease pathogenesis","volume":"12","author":"Bowirrat","year":"2022","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.ejmech.2023.115998_bib44","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1815915115","article-title":"Spatiotemporal activation of the C\/EBPbeta\/delta-secretase axis regulates the pathogenesis of Alzheimer\u2019s disease","volume":"115","author":"Wang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2023.115998_bib45","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3390\/antiox9090818","article-title":"Mitochondrial oxidative and nitrosative stress and Alzheimer disease","volume":"9","author":"Butterfield","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.ejmech.2023.115998_bib46","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3390\/antiox10081231","article-title":"Linking oxidative stress and proteinopathy in Alzheimer\u2019s disease","volume":"10","author":"Sharma","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.ejmech.2023.115998_bib47","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s11064-022-03855-y","article-title":"The effect and mechanism of syringa pinnatifolia hemsl. ligans on cerebral ischemia-reperfusion injury and oxidative stress in mice,","volume":"48","author":"Hao","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejmech.2023.115998_bib48","doi-asserted-by":"crossref","first-page":"120019","DOI":"10.1016\/j.jns.2021.120019","article-title":"Parkinsonism and cerebrospinal fluid disorders","volume":"433","author":"Youn","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejmech.2023.115998_bib49","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1021\/acs.jproteome.0c00747","article-title":"Proteomic profiling of the substantia nigra to identify determinants of lewy body pathology and dopaminergic neuronal loss","volume":"20","author":"Petyuk","year":"2021","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejmech.2023.115998_bib50","doi-asserted-by":"crossref","first-page":"114719","DOI":"10.1016\/j.bcp.2021.114719","article-title":"Activation of Nrf2 by methylene blue is associated with the neuroprotection against MPP+ induced toxicity via ameliorating oxidative stress and mitochondrial dysfunction","volume":"192","author":"Bhurtel","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115998_bib51","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3390\/ijms18091989","article-title":"Quercetin attenuates manganese-induced neuroinflammation by alleviating oxidative stress through regulation of apoptosis, iNOS\/NF-kappaB and HO-1\/Nrf2 pathways","volume":"18","author":"Bahar","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.115998_bib52","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1134\/S0006297918090043","article-title":"Molecular pathogenesis in Huntington\u2019s disease","volume":"83","author":"Illarioshkin","year":"2018","journal-title":"Biochemistry-Moscow+"},{"key":"10.1016\/j.ejmech.2023.115998_bib53","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1034\/j.1399-0004.2000.580108.x","article-title":"Atypical movement disorders in the early stages of Huntington\u2019s disease: clinical and genetic analysis","volume":"58","author":"Squitieri","year":"2000","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ejmech.2023.115998_bib54","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-2199-9-84","article-title":"Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington\u2019s disease","volume":"9","author":"van Roon-Mom","year":"2008","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/j.ejmech.2023.115998_bib55","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/antiox8090410","article-title":"Diallyl trisulfide protects rat brain tissue against the damage induced by ischemia-reperfusion through the Nrf2 pathway","volume":"8","author":"Silva-Islas","year":"2019","journal-title":"Antioxidants-Basel"},{"key":"10.1016\/j.ejmech.2023.115998_bib56","doi-asserted-by":"crossref","first-page":"106314","DOI":"10.1016\/j.intimp.2020.106314","article-title":"The role of chemokines and chemokine receptors in multiple sclerosis","volume":"83","author":"Cui","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2023.115998_bib57","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.3390\/cells11142260","article-title":"Hedgehog signaling in CNS remyelination","volume":"11","author":"Fang","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2023.115998_bib58","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3390\/antiox11061146","article-title":"Neurodegeneration in multiple sclerosis: the role of Nrf2-dependent pathways","volume":"11","author":"Maldonado","year":"2022","journal-title":"Antioxidants-Basel"},{"key":"10.1016\/j.ejmech.2023.115998_bib59","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.4103\/1673-5374.324841","article-title":"Amyotrophic lateral sclerosis, a neurodegenerative motor neuron disease with retinal involvement","volume":"17","author":"Ramirez","year":"2022","journal-title":"Neural. Regen. Res."},{"key":"10.1016\/j.ejmech.2023.115998_bib60","first-page":"630","article-title":"Targeting abnormal Nrf2\/HO-1 signaling in amyotrophic lateral sclerosis: current insights on drug targets and influences on neurological disorders","volume":"21","author":"Minj","year":"2021","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ejmech.2023.115998_bib61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/ph11030089","article-title":"Iron in Friedreich Ataxia: a central role in the pathophysiology or an epiphenomenon?","volume":"11","author":"Alsina","year":"2018","journal-title":"Pharmaceuticals-Base"},{"key":"10.1016\/j.ejmech.2023.115998_bib62","doi-asserted-by":"crossref","first-page":"E917","DOI":"10.1212\/WNL.0000000000006121","article-title":"Nonataxia symptoms in Friedreich Ataxia report from the registry of the european Friedreich\u2019s Ataxia consortium for translational studies (EFACTS)","volume":"91","author":"Reetz","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2023.115998_bib63","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.1074\/jbc.M408717200","article-title":"Friedreich\u2019s ataxia, no changes in mitochondrial labile iron in human lymphoblasts and fibroblasts: a decrease in antioxidative capacity?","volume":"280","author":"Sturm","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115998_bib64","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3390\/ijms18102173","article-title":"Nrf2-inducers counteract nneurodegeneration in frataxin-ssilenced motor neurons: disclosing new therapeutic targets for Friedreich\u2019s Ataxia","volume":"18","author":"Petrillo","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.115998_bib65","doi-asserted-by":"crossref","first-page":"105014","DOI":"10.1016\/j.neuint.2021.105014","article-title":"Role of microgliosis, oxidative stress and associated neuroinflammation in the pathogenesis of Parkinson\u2019s disease: the therapeutic role of Nrf2 activators","volume":"145","author":"Jayaram","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2023.115998_bib66","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.1021\/acs.jmedchem.9b01865","article-title":"Emerging substrate proteins of Kelch-like ECH associated protein 1 (Keap1) and potential challenges for the development of small-molecule inhibitors of the Keap1-nuclear factor erythroid 2-related factor 2 (Nrf2) protein-protein interaction","volume":"63","author":"Zhang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115998_bib67","doi-asserted-by":"crossref","first-page":"14481","DOI":"10.1021\/acs.jmedchem.2c00830","article-title":"Development of noncovalent small-molecule Keap1-Nrf2 inhibitors by fragment-based drug discovery","volume":"65","author":"Narayanan","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115998_bib68","doi-asserted-by":"crossref","first-page":"7186","DOI":"10.1021\/acs.jmedchem.5b00602","article-title":"Design, synthesis, and evaluation of triazole derivatives that induce Nrf2 dependent gene products and inhibit the Keap1-Nrf2 protein-protein interaction","volume":"58","author":"Bertrand","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115998_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006593","article-title":"Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer\u2019s disease","volume":"13","author":"Kerr","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ejmech.2023.115998_bib70","doi-asserted-by":"crossref","first-page":"104172","DOI":"10.1016\/j.bioorg.2020.104172","article-title":"Direct inhibition of Keap1-Nrf2 protein-protein interaction as a potential therapeutic strategy for Alzheimer\u2019s disease","volume":"103","author":"Sun","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115998_bib71","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1073\/pnas.0500815102","article-title":"Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress","volume":"102","author":"Dinkova-Kostova","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2023.115998_bib72","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.freeradbiomed.2013.07.022","article-title":"Nrf2\/ARE-mediated antioxidant actions of pro-electrophilic drugs","volume":"65","author":"Satoh","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2023.115998_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.389","article-title":"Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2\/ARE pathway in Alzheimer\u2019s disease models","volume":"7","author":"Lipton","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2023.115998_bib74","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1021\/acschemneuro.7b00100","article-title":"Targeting the Nrf2\/Amyloid-Beta liaison in Alzheimer\u2019s disease: a rational approach","volume":"8","author":"Simoni","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2023.115998_bib75","doi-asserted-by":"crossref","first-page":"5906189","DOI":"10.1155\/2017\/5906189","article-title":"Andrographolide activates Keap1\/Nrf2\/ARE\/HO-1 pathway in HT22 cells and suppresses microglial activation by Abeta42 through Nrf2-related inflammatory response","volume":"2017","author":"Seo","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejmech.2023.115998_bib76","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.freeradbiomed.2020.10.022","article-title":"NRF2 activation by reversible KEAP1 binding induces the antioxidant response in primary neurons and astrocytes of a Huntington\u2019s disease mouse model","volume":"162","author":"Moretti","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2023.115998_bib77","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2174\/1570159X18666200522201123","article-title":"Therapeutic and mechanistic effects of curcumin in Huntington\u2019s disease","volume":"19","author":"Labanca","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2023.115998_bib78","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ejmech.2017.11.048","article-title":"Activation of anti-oxidant Nrf2 signaling by enone analogues of curcumin","volume":"143","author":"Deck","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115998_bib79","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jnutbio.2011.12.010","article-title":"Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity","volume":"24","author":"Carmona-Ramirez","year":"2013","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.ejmech.2023.115998_bib80","first-page":"702","article-title":"KMS99220 exerts anti-inflammatory effects, activates the Nrf2 signaling and interferes with IKK, JNK and p38 MAPK via HO-1","volume":"42","author":"Lee","year":"2019","journal-title":"Mol. Cells"},{"key":"10.1016\/j.ejmech.2023.115998_bib81","doi-asserted-by":"crossref","first-page":"114617","DOI":"10.1016\/j.taap.2019.114617","article-title":"Tricetin protects against 6-OHDA-induced neurotoxicity in Parkinson\u2019s disease model by activating Nrf2\/HO-1 signaling pathway and preventing mitochondria-dependent apoptosis pathway","volume":"378","author":"Ren","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115998_bib82","doi-asserted-by":"crossref","first-page":"107989","DOI":"10.1016\/j.neuropharm.2020.107989","article-title":"Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson\u2019s disease animal model","volume":"167","author":"Kim","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2023.115998_bib83","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/jnc.14997","article-title":"BRUP-1, an intracellular bilirubin modulator, exerts neuroprotective activity in a cellular Parkinson\u2019s disease model","volume":"155","author":"Kataura","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2023.115998_bib84","first-page":"1","article-title":"Chlorhexidine as a Keap1-Nrf2 inhibitor: a new target for an old drug for Parkinson\u2019s disease therapy","author":"Unni","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2023.115998_bib85","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/md20030191","article-title":"Novel prenylated indole alkaloids with neuroprotection on SH-SY5Y cells against oxidative stress targeting Keap1-Nrf2","volume":"20","author":"Xiao","year":"2022","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2023.115998_bib86","doi-asserted-by":"crossref","first-page":"7885","DOI":"10.1039\/D2FO00357K","article-title":"Activation of Atg7-dependent autophagy by a novel inhibitor of the Keap1-Nrf2 protein-protein interaction from Penthorum chinense Pursh. attenuates 6-hydroxydopamine-induced ferroptosis in zebrafish and dopaminergic neurons","volume":"13","author":"Sun","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.ejmech.2023.115998_bib87","doi-asserted-by":"crossref","first-page":"8171","DOI":"10.1021\/jf301511m","article-title":"Baicalein protects against 6-OHDA-induced neurotoxicity through activation of Keap1\/Nrf2\/HO-1 and involving PKCalpha and PI3K\/AKT signaling pathways","volume":"60","author":"Zhang","year":"2012","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2023.115998_bib88","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/bph.12973","article-title":"A novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson\u2019s disease animal model,","volume":"172","author":"Lee","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115998_bib89","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuroscience.2014.11.047","article-title":"Dimethyl fumarate attenuates 6-ohda-induced neurotoxicity in sh-sy5y cells and in animal model of Parkinson\u2019s disease by enhancing Nrf2 activity","volume":"286","author":"Jing","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2023.115998_bib90","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.redox.2018.05.015","article-title":"Neuroprotection against 6-OHDA toxicity in PC12 cells and mice through the Nrf2 pathway by a sesquiterpenoid from Tussilago farfara","volume":"18","author":"Lee","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2023.115998_bib91","doi-asserted-by":"crossref","first-page":"112385","DOI":"10.1016\/j.ejmech.2020.112385","article-title":"Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson\u2019s disease via the activation of Nrf2\/Keap1 pathway","volume":"199","author":"Wang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115998_bib92","doi-asserted-by":"crossref","first-page":"6688708","DOI":"10.1155\/2021\/6688708","article-title":"Fucoxanthin prevents 6-OHDA-induced neurotoxicity by targeting Keap1, Oxid","volume":"2021","author":"Wu","year":"2021","journal-title":"Med. Cell. Longev"},{"key":"10.1016\/j.ejmech.2023.115998_bib93","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","article-title":"Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway","volume":"134","author":"Linker","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ejmech.2023.115998_bib94","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/febs.15485","article-title":"Structural insights into the multiple binding modes of Dimethyl Fumarate (DMF) and its analogs to the Kelch domain of Keap1","volume":"288","author":"Unni","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2023.115998_bib95","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.4049\/jimmunol.1601532","article-title":"Dimethyl fumarate selectively reduces memory T cells and shifts the balance between Th1\/Th17 and Th2 in Multiple Sclerosis patients","volume":"198","author":"Wu","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2023.115998_bib96","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.3390\/ijms22063168","article-title":"A state of the art of antioxidant properties of curcuminoids in neurodegenerative diseases","volume":"22","author":"Silvestro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.115998_bib97","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuropharm.2015.07.013","article-title":"Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair","volume":"99","author":"Mohajeri","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2023.115998_bib98","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12031-017-1022-x","article-title":"Neuroprotective effects of melatonin on experimental allergic encephalomyelitis mice via anti-oxidative stress activity","volume":"64","author":"Long","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2023.115998_bib99","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4049\/jimmunol.181.1.680","article-title":"The transcription factor Nrf2 is a therapeutic target against brain inflammation,","volume":"181","author":"Innamorato","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2023.115998_bib100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.expneurol.2013.10.002","article-title":"Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice","volume":"250","author":"Li","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejmech.2023.115998_bib101","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejphar.2017.02.044","article-title":"The novel Nrf2 inducer TFM-735 ameliorates experimental autoimmune encephalomyelitis in mice","volume":"802","author":"Higashi","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115998_bib102","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/srep00201","article-title":"Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitis","volume":"1","author":"Pareek","year":"2011","journal-title":"Sci. Rep-Uk"},{"key":"10.1016\/j.ejmech.2023.115998_bib103","doi-asserted-by":"crossref","first-page":"9886","DOI":"10.1038\/s41598-017-06907-4","article-title":"A unique tolerizing dendritic cell phenotype induced by the synthetic triterpenoid CDDO-DFPA (RTA-408) is protective against EAE","volume":"7","author":"Wei","year":"2017","journal-title":"Sci. Rep-Uk"},{"key":"10.1016\/j.ejmech.2023.115998_bib104","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.freeradbiomed.2011.03.027","article-title":"Neuroprotective effect of Nrf2\/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis","volume":"51","author":"Neymotin","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2023.115998_bib105","first-page":"878030","article-title":"Nrf2\/ARE signaling pathway: key mediator in oxidative stress and potential therapeutic target in ALS","volume":"2012","author":"Petri","year":"2012","journal-title":"Neurol. Res. Int"},{"key":"10.1016\/j.ejmech.2023.115998_bib106","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.2147\/OTT.S136992","article-title":"safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors","volume":"10","author":"Creelan","year":"2017","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejmech.2023.115998_bib107","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fncel.2018.00188","article-title":"Novel Nrf2-inducer prevents mitochondrial defects and oxidative stress in Friedreich\u2019s Ataxia models","volume":"12","author":"Abeti","year":"2018","journal-title":"Front. Cell. Neurosci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423009650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423009650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:57:33Z","timestamp":1759330653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423009650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":107,"alternative-id":["S0223523423009650"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115998","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent progress and applications of small molecule inhibitors of Keap1\u2013Nrf2 axis for neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115998","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115998"}}